Deciphering high risk molecular alterations in gastrointestinal malignancy utilizing an extreme outlier strategy
Oncoscience
.
2020 May 5;7(5-6):26-29.
doi: 10.18632/oncoscience.503.
eCollection 2020 May.
Authors
Austin R Dosch
1
,
Siddharth Mehra
1
,
Nipun B Merchant
1
,
Jashodeep Datta
1
Affiliation
1
Division of Surgical Oncology, Dewitt Daughtry Department of Surgery, University of Miami Miller School of Medicine, Sylvester Comprehensive Cancer Center, Miami, FL, USA.
PMID:
32676512
PMCID:
PMC7343576
DOI:
10.18632/oncoscience.503
No abstract available
Keywords:
extreme outlier; gastrointestinal cancer; genomic; high risk; prognosis.
Grants and funding
R01 CA161976/CA/NCI NIH HHS/United States
UL1 TR002736/TR/NCATS NIH HHS/United States
T32 CA211034/CA/NCI NIH HHS/United States
UL1 TR000460/TR/NCATS NIH HHS/United States
P30 CA240139/CA/NCI NIH HHS/United States